Protective effects of silymarin on epirubicin-induced mucosal barrier injury of the gastrointestinal tract

References

• Abascal K, Yarnell E. (2003). The many faces of Silybum marianum (Milk Thistle). Alternat Complement Ther 9:251–256
   Google Scholar
• Ahmad I, Shuka S, Kumar A, et al. (2013). Biochemical and molecular mechanisms of N-acetyl cysteine and sylimarin-mediated protection against maneb- and paraquat induced hepatotoxicity in rats. Chem Biol Interact 201:9–18
   PubMed Web of Science ®Google Scholar
• Al-Dasooqi N, Sonis ST, Bowen JM, et al. (2013). Emerging evidence on the pathobiology of mucositis. Support Care Cancer 21:3233–3241
   PubMed Web of Science ®Google Scholar
• Alderton PM, Gross J, Green MD. (1992). Comparative study of doxorubicin, mitoxantrone, and epirubicin in combination with ICRF-187 (ADR-529) in a chronic cardiotoxicity animal model. Cancer Res 52:194–201
   PubMed Web of Science ®Google Scholar
• Barcelo A, Claustre J, Moro F, et al. (2000). Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon. Gut 46:218–224
   PubMed Web of Science ®Google Scholar
• Bowen J, Gibson R, Keefe DM, Cummings AG. (2005). Cytotoxic chemotherapy upregulates pro-apoptotic Bax and Bak in the small intestine of rats and humans. Pathology 37:56–62
   PubMed Web of Science ®Google Scholar
• Bowen JM, Gibson RJ. (2006). Cummins Dorothy M. K. Keefe, Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage. Support Care Cancer 14:713–731
   PubMed Web of Science ®Google Scholar
• Buschini A, Poli P, Rossi C. (2003). Saccharomyces cerevisiae as an eukaryotic cell model to assess cytotoxicity and genotoxicity of three anticancer anthraquinones. Mutagenesis 18:25–36
   PubMed Web of Science ®Google Scholar
• Carneiro-Filho BA, Oriá RB, Wood Rea K, et al. (2004). Alanyl-glutamine hastens morphologic recovery from 5-fluorouracil-induced mucositis in mice. Nutrition 20:934–941
   PubMed Web of Science ®Google Scholar
• Cawley MM, Benson LM. (2005). Current trends in managing oral mucositis. Clin J Oncol Nurs 9:584–592
   PubMedGoogle Scholar
• Charak S, Jangir DK, Tyagi G, Mehrotra R. (2011). Interaction studies of Epirubicin with DNA using spectroscopic techniques. J Cryst Mol Struct 1000:150–154
   Web of Science ®Google Scholar
• Chung-Ta C, Tin-Yun H, Ho L, et al. (2012). 5-Fluorouracil induced intestinal mucositis via nuclear factor-kB activation by transcriptomic analysis and in vivo bioluminescence imaging. PLoS One 7:e31808
   PubMed Web of Science ®Google Scholar
• Esmaily H, Vaziri-Bami A, Miroliae AE, et al. (2011). The correlation between NF-jB inhibition and disease activity by coadministration of silibinin and ursodeoxycholic acid in experimental colitis. Fundam Clin Pharm 25:723–733
   PubMed Web of Science ®Google Scholar
• Gaurav K, Goel RK, Shukla M, Pandey M. (2012). Glutamine: a novel approach to chemotherapy-induced toxicity. Indian J Med Paediatr Oncol 33:13–20
   PubMedGoogle Scholar
• Gibson R. (2007). Establishment of a single-dose irinotecan model of gastrointestinal mucositis. Chemotherapy 53:360–369
   PubMed Web of Science ®Google Scholar
• Gibson R, Bowen J, Keefe D. (2008). Technological advances in mucositis research: new insights and new issues. Cancer Treat Rev 34:476–482
   PubMed Web of Science ®Google Scholar
• Girish C, Koner B, Jaianthy S, et al. (2009). Hepatoprotective activity of picroliv, curcumin and ellagic acid compared to silymarin on paracetamol induced liver toxicity in mice. Fundam Clin Pharm 23:735–745
   PubMed Web of Science ®Google Scholar
• Greenle H, Abscal K, Yarnell E, Ladas E. (2007). Clinical applications of Silybum marianum in oncology. Integr Cancer Ther 6:158–165
   PubMed Web of Science ®Google Scholar
• Jain A, Yadav A, Bozhkov AI, et al. (2011). Therapeutic efficacy of silymarin and naringenin in reducing arsenic-induced hepatic damage in young rats. Ecotox Environ Safe 74:607–614
   PubMed Web of Science ®Google Scholar
• Jensen SB, Mouridsen HT, Bergmann OJ, et al. (2008). Oral mucosal lesions, microbial changes, and taste disturbances induced by adjuvant chemotherapy in breast cancer patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:217–226
   PubMed Web of Science ®Google Scholar
• Jiang Y, Wang H, Jing Wang J, et al. (2009). The protective effect of silibinin against mitomycin C-induced intrinsic apoptosis in human melanoma A375-S2 cells. J Pharmacol Sci 111:137–146
   PubMed Web of Science ®Google Scholar
• Kaczmarek A, Brinkman BM, Heyndrickx L, et al. (2012). Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways. J Pathol 226:598–608
   PubMed Web of Science ®Google Scholar
• Kanareka N, Grivennikovb SI, Leshetsa M, et al. (2014). Critical role for IL-1β in DNA damage-induced mucositis. Proc Natl Acad Sci USA 111:E702–E711
   PubMed Web of Science ®Google Scholar
• Kaya A, Coskun U, Buyukberber S, et al. (2010). Efficacy and toxicity of preoperative chemotherapy with docetaxel and epirubicin in locally advanced invasive breast cancer. J Buon 15:248–254
   PubMed Web of Science ®Google Scholar
• Keefe DM, Schubert MM, Elting LS, et al. (2007). Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820–831
   PubMed Web of Science ®Google Scholar
• Kerr J, Winterford C, Harmon B. (1994). Apoptosis: its significant in cancer and cancer therapy. Cancer 73:2013–2026
   PubMed Web of Science ®Google Scholar
• Komarova EA, Gudkov AV. (2000). Suppresion of p53: a new approach to overcome side effects of antitumor therapy. Biochemistry 65:657–667
   Google Scholar
• Komarova EA, Gudkov AV. (2001). Chemoprotection from p53-dependent apoptosis: potential clinical applications of the p53 inhibitors. Biochem Pharmacol 62:657–667
   PubMed Web of Science ®Google Scholar
• Komarova EA, Neznanov N, Komarov PG, et al. (2003). p53 inhibitor pifithrin alpha can suppress heat shock and glucocorticoid signaling pathways. J Biol Chem 278:15465–15468
   PubMed Web of Science ®Google Scholar
• Kshirsagar A, Ingawale D, Ashok P, Vyawahare N. (2009). Silymarin: a comprehensive review. Phcog Rev 3:126–134
   Google Scholar
• Logan RM, Gibson RJ, Sonis ST. (2007). Nuclear factor-kappaB (NF-kappaB) and cycloxygenase-2 (COX-2) expression in oral mucosa following cancer chemotherapy. Oral Oncol 43:395–401
   PubMed Web of Science ®Google Scholar
• Loo W, Jin LJ, Chow L, et al. (2010). Rhodiola algida improves chemotherapy-induced oral mucositis in breast cancer patients. Expert Opin Investig Drugs 19:S91–S100
   PubMed Web of Science ®Google Scholar
• Merritt AJ, Potten CS, Watson AJ, et al. (1995). Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J Cell Sci 108:2261–2271
   PubMed Web of Science ®Google Scholar
• Morelli D, Menard S, Colnaghi MI. (1996). Oral administration of anti-doxorubicin monoclonal antibody prevents chemotherapy-induced gastrointestinal toxicity in mice. Cancer Res 56:2082–2085
   PubMed Web of Science ®Google Scholar
• Olinski R, Jaruga P, Foksinski M, et al. (1997). Epirubicin-induced oxidative DNA damage and evidence for its repair in lymphocytes of cancer patients who are undergoing chemotherapy. Mol Pharmacol 52:882–885
   PubMed Web of Science ®Google Scholar
• Ozkan A, Fiskin K. (2004). Epirubicin HCl toxicity in human-liver derived hepatoma G2 cells. Pol J Pharmacol 56:435–444
   PubMedGoogle Scholar
• Patel N, Joseph C, Corcoran GB, Ray SD. (2010). Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver. Toxicol Appl Pharmacol 245:143–153
   PubMed Web of Science ®Google Scholar
• Peterson DE, Keefe DM, Hutchins RD, Schubert MM. (2006). Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practice. Support Care Cancer 14:499–504
   PubMed Web of Science ®Google Scholar
• Pritchard DM, Potten CS, Hickman JA. (1998). The relationship between p53-dependent apoptosis, inhibition of proliferation and 5-fluorouracil-induced histopathology in murine small intestinal epithelia. Cancer Res 58:5453–5465
   PubMed Web of Science ®Google Scholar
• Radko L, Cybulski W. (2007). Application of silymarin in human and animal medicine. J Pre-Clin Clin Res 1:022–026
   Google Scholar
• Raskovic A, Stilinovic N, Kolarovic J, et al. (2011). The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats. Molecules 16:8601–8613
   PubMed Web of Science ®Google Scholar
• Rooseboom A, Commandeur J, Vermeulen N. (2004). Enzyme-catalyzed activation of anticancer prodrugs. Pharmacol Rev 56:53–102
   PubMed Web of Science ®Google Scholar
• Ruemmele FM, Russo P, Beaulieu J, et al. (1999). Susceptibility to FAS-induced apoptosis in human non-tumoral enterocytes the role of co-stimulatory factors. J Cell Physiol 181:45–54
   PubMed Web of Science ®Google Scholar
• Sonis ST. (2004). The pathobiology of mucositis. Nat Rev Cancer 4:277–284
   PubMed Web of Science ®Google Scholar
• Sonis ST. (2010). New thoughts on the initiation of mucositis. Oral Dis 16:597–600
   PubMed Web of Science ®Google Scholar
• Sonis ST. (2011). Oral mucositis. Anti-Cancer Drugs 22:607–612
   PubMed Web of Science ®Google Scholar
• Sonis S, Keefe DM. (2013). Pathobiology of cancer regimen-related toxicities. New York: Springer Science+Business Media
   Google Scholar
• Stringer AM, Gibson RJ, Bowen JM, et al. (2007). Chemotherapy-induced mucositis: the role of gastrointestinal microflora and mucins in the luminal environment. J Support Oncol 5:259–267
   PubMedGoogle Scholar
• Sun Z, Wang X, Wallen R, et al. (1998). The influence of apoptosis on intestinal barrier integrity in rats. Scand J Gastroenterol 33:415–422
   PubMed Web of Science ®Google Scholar
• Sung L, Tomlinson GA, Greenberg ML, et al. (2007). Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patients. Eur J Cancer 43:1269–1275
   PubMed Web of Science ®Google Scholar
• Tunca R, Sozmen M, Citil M, et al; Pyridine induction of cytochrome P4501A1. (2009). iNOS and metallothionein in Syrian hamsters and protective effects of silymarin. Exp Toxicol Pathol 61:243–255
   PubMed Web of Science ®Google Scholar
• Upadhyay G, Singh AK, Kumar A, et al. (2008). Resveratrol modulates pyrogallol-induced changes in hepatic toxicity markers, xenobiotic metabolizing enzymes and oxidative stress. Eur J Pharmacol 596:146–152
   PubMed Web of Science ®Google Scholar
• van’t Land B, van Beek NM, van den Berg JJ, M’Rabet L. (2004). Lactoferrin reduces methotrexate-induced small intestinal damage, possibly through inhibition of GLP-2-mediated epithelial cell proliferation. Dig Dis Sci 49:425–433
   PubMed Web of Science ®Google Scholar
• Yeoh A, Gibson R, Yeoh E, et al. (2006). Radiation therapy-induced mucositis: relationships between fractionated radiation, NF-kappaB, COX-1, and COX-2. Cancer Treat Review 32:645–651
   PubMed Web of Science ®Google Scholar